WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the ...

DUNDALK, Ireland, June 16, 2025 /PRNewswire/ -- WuXi Biologics (2269), a leading global Contract Research, Development, and Manufacturing Organiza Tuesday, 02 January 2024 12:17 GMT عربي ...

MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and expanding its vaccine production capabilities.

DUNDALK, Ireland, Nov. 22, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for ...

DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that ...

- Largest manufacturing scale to date achieved by combining four 4,000-liter single-use bioreactors DUNDALK, Ireland, Jan. 31, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading ...

DUNDALK, Ireland, Dec. 5, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced major ...

DUNDALK, Ireland, March 10, 2020/ PRNewswire/-- WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, ...

From renewable energy and workforce diversity to local partnerships and sustainable technology, WuXi Biologics' Dundalk site is redefining responsible growth in biomanufacturing. DUNDALK, Ireland ...

WuXi Biologics’ vaccines division will spend $240 million to build a facility in Dundalk, Ireland. The plant will be located on the same campus as a $390 million biologic drug manufacturing ...